Nanoscale Reaction Chambers for Preserving Cell-Specific Assay Data

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current assay formats lose cell-specific information during processing due to cell pooling, leading to a need for an assay platform that retains and links functional single-cell data with genomic, transcriptomic, and proteomic information.

Innovation Solution

Nanoscale reaction chambers (nanovials) are used to conduct cell-specific assays, maintaining information throughout the process and enabling correlation with genomic, transcriptomic, and proteomic analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If cell pooling is used in standard assay formats, then processing efficiency is improved, but cell-specific information is lost

Engineering Contradiction:
Improveprocessing efficiencyVSAvoidcell-specific information
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The invention segments the assay process into individual nanovial chambers, each containing a single cell or small cell group. This segmentation allows independent processing of each chamber while maintaining the ability to pool data across chambers, thus preserving cell-specific information without sacrificing overall processing efficiency.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The nanovial serves as an intermediary container that bridges the gap between single-cell analysis and pooled processing. It maintains cell-specific identity through unique identifiers while enabling standardized processing protocols, effectively mediating between the need for individual cell tracking and bulk processing efficiency.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If single-cell based assays are performed, then cell-specific information is retained, but assay complexity increases

Engineering Contradiction:
Improvecell-specific information retentionVSAvoidassay complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The nanovial platform provides a universal chamber design that can accommodate multiple assay types (functional assays, genomic analysis, transcriptomic analysis) within the same basic structure. This multi-functionality reduces overall system complexity by using a single platform for diverse applications rather than requiring separate specialized systems for each assay type.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The assay methodology employs nested analysis where functional assays are performed within nanovials that contain cells, which are then subjected to genomic and transcriptomic analysis. The unique identifiers from outer assays are carried through to inner assays, creating a nested structure that manages complexity through hierarchical organization rather than parallel independent systems.

Inventive Principle:
Principle #7Nested doll (Nesting)

3Adaptability or versatility

If multi-dimensional analysis is implemented, then analysis comprehensiveness is improved, but data processing complexity increases

Engineering Contradiction:
Improveanalysis comprehensivenessVSAvoiddata processing complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The platform incorporates feedback mechanisms where data from functional assays inform subsequent genomic and transcriptomic analysis priorities. This feedback loop allows the system to focus computational resources on the most relevant data points, reducing overall processing complexity while maintaining comprehensive multi-dimensional analysis through targeted rather than brute-force approaches.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20250264477A1Nanoscale reaction chambers and methods of using the same
Publication Date: 2025.08.21 PARTILLION BIOSCIENCE CORP
  • US20250264477A1 patent drawing
  • US20250264477A1 patent drawing
  • US20250264477A1 patent drawing

AI summary

Provided are nanoscale reaction chambers and methods of using the nanoscale reaction chambers for biological assays.